FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Mylan Pharmaceuticals Doxazosin Tablets Recall

Doxazosin Tablets, USP, 2 mg, 100 count bottles, labeled in part ***Manufactured in Aus…

Mylan Pharmaceuticals Inc. · Morgantown, WV

Risk level
Class II
Reported by FDA
Oct 31, 2012
Recall ID
D-033-2013
Check your lot numberHow we source this data

Summary

Mylan Pharmaceuticals recalled Doxazosin Tablets starting Aug 7, 2012. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-033-2013 on Oct 31, 2012. Reason: Cross Contamination w/Other Products: During stability testing chromatographic review revealed extraneous peaks identified as acetaminophen and codeine. Status: Terminated.

Why it was recalled

Cross Contamination w/Other Products: During stability testing chromatographic review revealed extraneous peaks identified as acetaminophen and codeine.

Product description

Doxazosin Tablets, USP, 2 mg, 100 count bottles, labeled in part ***Manufactured in Australia by: ALPHAPHARM PTY LTD, 15 Garnet Street***Rx Only*** Carole Park QLD 4300, Australia*** Manufactured for Mylan Pharmaceuticals Inc., Morgantown, WV 26505 U.SA ***

Lot numbers, UPCs & expiration codes

Lot A 303M, Exp. June 2014

Where it was sold

Nationwide.

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-033-2013
Classification
Class II
Status
Terminated
Recall initiated
Aug 7, 2012
FDA report date
Oct 31, 2012
Quantity
24,331 bottles
Recall type
Voluntary: Firm initiated
Recalling firm
Mylan Pharmaceuticals Inc.

Original FDA data

Every field from FDA enforcement report D-033-2013, exactly as published.

Show all FDA fields
City
Morgantown
State
WV
Status
Terminated
Country
United States
Event ID
63284
Address
781 Chestnut Ridge Rd
Code information
Lot A 303M, Exp. June 2014
Postal code
26505-2730
Report date
Oct 31, 2012
Product type
Drugs
Recall number
D-033-2013
Classification
Class II
Recalling firm
Mylan Pharmaceuticals Inc.
Product quantity
24,331 bottles
Termination date
Mar 27, 2013
Reason for recall
Cross Contamination w/Other Products: During stability testing chromatographic review revealed extraneous peaks identified as acetaminophen and codeine.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Doxazosin Tablets, USP, 2 mg, 100 count bottles, labeled in part ***Manufactured in Australia by: ALPHAPHARM PTY LTD, 15 Garnet Street***Rx Only*** Carole Park QLD 4300, Australia*** Manufactured for Mylan Pharmaceuticals Inc., Morgantown, WV 26505 U.SA ***
Distribution pattern
Nationwide.
Recall initiation date
Aug 7, 2012
Initial firm notification
Letter
Center classification date
Oct 25, 2012

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-033-2013, published Oct 31, 2012. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls